Column Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Column Capital Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$28.4K	Hold	400	–	–	﹤0.01%	396
2023 Q2	$30.8K	Hold	400	–	–	﹤0.01%	383
2023 Q1	$30.1K	Hold	400	–	–	﹤0.01%	387
2022 Q4	$31.5K	Hold	400	–	–	0.01%	358
2022 Q3	$28K	Hold	400	–	–	0.01%	342
2022 Q2	$32K	Hold	400	–	–	0.01%	333
2022 Q1	$30K	Hold	400	–	–	0.01%	353
2021 Q4	$34K	Sell	400 -13	-3%	-$1.01K	0.01%	347
2021 Q3	$31K	Hold	413	–	–	0.01%	336
2021 Q2	$34K	Sell	413 -1	-0.2%	-$82	0.01%	326
2021 Q1	$33K	Hold	414	–	–	0.01%	321
2020 Q4	$35K	Hold	414	–	–	0.01%	316
2020 Q3	$32K	Sell	414 -402	-49%	-$30.7K	0.01%	308
2020 Q2	$59K	Sell	816 -2	-0.2%	-$142	0.02%	223
2020 Q1	$54K	Hold	818	–	–	0.02%	189
2019 Q4	$56K	Buy	+818	New	+$55.8K	0.03%	224

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Column Capital Advisors's CL Position: Q3 2023 in Review

Column Capital Advisors held its Colgate-Palmolive (CL) position steady in Q3 2023 at 400 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

Column Capital Advisors first reported a position in CL in Q4 2019 and has held it in 16 quarters since. The position peaked at $59K in Q2 2020. 1,621 funds tracked by Wall St. Rank hold CL as of Q3 2023.

Column Capital Advisors held 400 shares of Colgate-Palmolive worth $28.4K as of Q3 2023.
Column Capital Advisors left its Colgate-Palmolive share count unchanged in Q3 2023.
Colgate-Palmolive made up ﹤0.01% of Column Capital Advisors's portfolio in Q3 2023, its #396 holding.
Column Capital Advisors first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 16 quarters since.
Column Capital Advisors's Colgate-Palmolive position peaked at $59K in Q2 2020.
1,621 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.